# I wish to not have my investment company pull the plug and keep being a good company like they have been
benb24
reacted to and commented on
Join moomoo at our CBOE Index Options Launch Party!
We're excited to announce the launch of index options on the moomoo platform and our newpartnership with CBOE, the creator of index options and the world's Ieading derivatives andsecurities exchange network.
To celebrate, we're having a party with CBOE - and we would be thrilled if you would join us.
![We're having an event and you're invited!](https://ussnsimg.moomoo.com/77777001/editor_image/4585f98200dc318abee24a59cc6625fe.jpg/thumb)
53
4
benb24
liked
The market's opinion of the firm seems improved compared to five years ago, with a 25% average annual rise in share price possibly indicative. A recent positive atmosphere and robust price momentum may hint at an opportunity.
1
benb24
liked
These declining returns and stable capital may indicate a mature business facing new competition or smaller margins. Given that these trends are not typically conducive to a multi-bagger return, it is advised to exercise caution with Wangsu Science & TechnologyLtd.
1
benb24
liked
Based on the secrecy around its use of generative AI, it's possible that Apple may be preparing a novel application for it, which could potentially enhance their product line.
1
benb24
liked
Despite a dip in share price this year, the stock may still present attractive opportunities if sustainable long-term growth is evident. Investors hold the company in higher esteem due to its growth track record.
1
benb24
liked
Despite a 51% stock decline, Jinko Solar's positive ROCE trend and capital increase suggest potential multi-bagger status - an opportunity for investors. Further research is advised to assess if these trends continue.
1
benb24
liked
Canny Elevator's rising ROCE indicates improved business efficiencies, but a high current liabilities ratio suggests some risk. A bright future for the stock is predicted if it maintains its ROCE trends.
1
benb24
liked
$Cardiff Oncology (CRDF.US)$ Earnings good! Pipeline great with several phase 2! fixing to start dosing of first patient in first line RAS mutated metastatic colorectal cancer! Among lots of others! also with current cash burn, they should have enough capital for continued operations through 2025. So i dont see a offering anytime soon? If you want more look at 8K from 9/26/23 and that will get you to the new Corporate Presentation! Good Stuff in there!![]()
2
benb24
liked
The company's 48% drop in revenue last year to CN¥1.4b, along with an EBIT loss of CN¥403m, raises concerns for its sustainability and investor appeal amidst growing debts and liabilities.
1